1ST-301

N/A

Report date: 2022/11/01 18:11:04
NME

Base Information

Drug Name1ST-301
Drug Alias Name1ST-301
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRett Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator Companies1st Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active Companies1st Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsRett Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A